We are live on ! Find out more
REPL icon

Replimune Group

149 hedge funds and large institutions have $638M invested in Replimune Group in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

33% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 45

16% more capital invested

Capital invested by funds: $548M → $638M (+$90.3M)

6.23% more ownership

Funds ownership: 109.21%115.44% (+6.2%)

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

1% less funds holding

Funds holding: 150149 (-1)

33% less call options, than puts

Call options by funds: $399K | Put options by funds: $599K

Holders
149
Holders Change
-1
Holders Change %
-0.67%
% of All Funds
2.15%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
28
Increased
60
Reduced
45
Closed
27
Calls
$399K
Puts
$599K
Net Calls
-$200K
Net Calls Change
+$316K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$4.75M +$42.4K +6,090 +1%
PHP
27
Parkman Healthcare Partners
Connecticut
$4.72M +$3.66M +525,000 New
Northern Trust
28
Northern Trust
Illinois
$4.17M -$142K -20,385 -4%
Norges Bank
29
Norges Bank
Norway
$4.14M
GTC
30
Ghost Tree Capital
New York
$4.05M -$1.39M -200,000 -31%
Charles Schwab
31
Charles Schwab
California
$3.89M +$95K +13,635 +3%
Wellington Management Group
32
Wellington Management Group
Massachusetts
$3.65M +$667K +95,737 +31%
WP
33
Woodline Partners
California
$2.64M
TD Asset Management
34
TD Asset Management
Ontario, Canada
$2.25M +$77.3K +11,094 +5%
JP Morgan Chase
35
JP Morgan Chase
New York
$2.17M -$215K -30,858 -11%
N
36
Nuveen
North Carolina
$2.09M +$801K +114,980 +98%
Citadel Advisors
37
Citadel Advisors
Florida
$1.93M +$1.03M +147,446 +219%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$1.89M -$89.9K -12,900 -6%
Two Sigma Investments
39
Two Sigma Investments
New York
$1.86M -$710K -101,821 -33%
UOC
40
UBS O'Connor
Illinois
$1.86M +$791K +113,445 +122%
NFGH
41
Nan Fung Group Holdings
Hong Kong
$1.84M
Acadian Asset Management
42
Acadian Asset Management
Massachusetts
$1.67M +$501K +71,867 +63%
HF
43
HRT Financial
New York
$1.66M +$1.29M +184,761 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$1.66M +$610K +87,509 +91%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$1.62M +$122K +17,471 +11%
PP
46
PDT Partners
New York
$1.43M +$1.11M +158,770 New
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.33M -$4.55K -653 -0.4%
CF
48
Cantor Fitzgerald
New York
$1.31M +$1.02M +145,919 New
Renaissance Technologies
49
Renaissance Technologies
New York
$1.31M -$111K -15,900 -10%
JGC
50
J. Goldman & Co
New York
$1.22M +$948K +136,050 New

REPL Hedge Fund Activity: Q2 2024 in Review

149 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2024, worth a combined $638M — up 16% from $548M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new REPL positions and 27 closed out — a net gain of 1 holder — while 60 added to existing stakes and 45 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $18.7M. The largest seller was State Street, cutting an estimated $37.1M.

  • 149 institutional investors held Replimune Group (REPL) as of Q2 2024, down from 150 in Q1 2024.
  • Funds reported $638M of Replimune Group stock for Q2 2024, up 16% quarter-over-quarter.
  • 28 funds opened new Replimune Group positions in Q2 2024 and 27 closed out, a net change of +1 holder.
  • The largest Replimune Group buyer in Q2 2024 was T. Rowe Price Associates, an estimated $18.7M added.
  • The largest Replimune Group seller in Q2 2024 was State Street, an estimated $37.1M sold.

Based on aggregated 13F filings for Q2 2024.